InSphero partners with Chayon in South Korea for in vitro technologies

InSphero, the pioneer in 3D cell culture and organ-on-chip technologies, today announced its distribution partnership with Chayon, a leading Seoul-based laboratory supplies provider. This partnership will bring InSphero’s reliable and scalable 3D in vitro solutions for drug development to South Korean researchers, further expanding the company’s global footprint.

Chayon, well-known for its expertise in distributing high-quality laboratory equipment, is the exclusive distributor for Yokogawa systems in Korea. As they venture into the 3D Cell Culture market, this new partnership positions them to offer InSphero’s innovative Akura Plate Technology and Akura Organ-on-Chip Platforms to a broader audience. InSphero’s 3D technologies complement Yokogawa’s advanced systems, making this partnership an ideal solution for researchers seeking to enhance their drug development and safety testing efforts.

“We are very pleased to welcome the Chayon team to our network of distributors, their technical knowledge and the long relationship with Yokogawa are key for us to support research activities in Korea,” said Paul Clémençon, Chief Business Officer at InSphero. “Chayon’s deep knowledge of laboratory equipment and their expanding portfolio of consumables make them an ideal partner for us.”

Chayon’s team brings decades of experience in delivering innovative solutions to the scientific community. Their reputation for excellence in customer service and technical support will help ensure that South Korean researchers can seamlessly integrate InSphero’s advanced 3D in vitro products into their laboratories.

Minah Lee, Chayon’s Managing Director shares the enthusiasm: “We are happy to distribute leading-edge 3D cell culture technology of in Sphero. As InSphero’s distributor, Chayon Lab. Inc. can maximize portfolio synergy with existing products like high-content imaging system and live cell imaging system, enhancing research accuracy and expanding customer reach. Additionally, the complementary solutions strengthen research efficiency in the pharmaceutical and life sciences sectors."

This partnership highlights InSphero’s commitment to expanding the reach of its 3D in vitro solutions globally, providing researchers with innovative tools to advance scientific discovery.